Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exagen (XGN) Return on Sales (2018 - 2025)

Exagen's Return on Sales history spans 8 years, with the latest figure at 0.28% for Q4 2025.

  • For Q4 2025, Return on Sales fell 1.0% year-over-year to 0.28%; the TTM value through Dec 2025 reached 0.3%, down 3.0%, while the annual FY2025 figure was 0.3%, 3.0% down from the prior year.
  • Return on Sales reached 0.28% in Q4 2025 per XGN's latest filing, up from 0.41% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.2% in Q2 2024 to a low of 1.93% in Q2 2022.
  • Average Return on Sales over 5 years is 0.55%, with a median of 0.41% recorded in 2023.
  • Peak YoY movement for Return on Sales: crashed -143bps in 2022, then soared 157bps in 2023.
  • A 5-year view of Return on Sales shows it stood at 0.56% in 2021, then plummeted by -112bps to 1.18% in 2022, then surged by 66bps to 0.4% in 2023, then skyrocketed by 32bps to 0.28% in 2024, then fell by -2bps to 0.28% in 2025.
  • Per Business Quant, the three most recent readings for XGN's Return on Sales are 0.28% (Q4 2025), 0.41% (Q3 2025), and 0.26% (Q2 2025).